esmolol hydrochloride · Hq Spclt Pharma · NDA 205703

Esmolol Hydrochloride In Plastic Container

Earliest generic entry, as listed
15 Mar 2033

Blocked by patent: US 8829054, US 8835505.

Listed patents · 2 unexpired

PatentClaimsExpires
US 8829054product15 Mar 2033
US 8835505product15 Mar 2033

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 1

NDA · productFormStrengthListed expiry
205703 · 001 · RLDsolution, intravenous2.5GM/250ML (10MG/ML)15 Mar 2033